Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Auxiliary trafficking subunit GJA1-20k protects connexin-43 from degradation and limits ventricular arrhythmias
Shaohua Xiao, … , TingTing Hong, Robin M. Shaw
Shaohua Xiao, … , TingTing Hong, Robin M. Shaw
Published June 11, 2020
Citation Information: J Clin Invest. 2020;130(9):4858-4870. https://doi.org/10.1172/JCI134682.
View: Text | PDF
Research Article Cardiology Cell biology

Auxiliary trafficking subunit GJA1-20k protects connexin-43 from degradation and limits ventricular arrhythmias

  • Text
  • PDF
Abstract

Connexin-43 (Cx43) gap junctions provide intercellular coupling, which ensures rapid action potential propagation and synchronized heart contraction. Alterations in Cx43 localization and reductions in gap junction coupling occur in failing hearts, contributing to ventricular arrhythmias and sudden cardiac death. Recent reports have found that an internally translated Cx43 isoform, GJA1-20k, is an auxiliary subunit for the trafficking of Cx43 in heterologous expression systems. Here, we have created a mouse model by using CRISPR technology to mutate a single internal translation initiation site in Cx43 (M213L mutation), which generates full-length Cx43, but not GJA1-20k. We found that GJA1M213L/M213L mice had severely abnormal electrocardiograms despite preserved contractile function, reduced total Cx43, and reduced gap junctions, and they died suddenly at 2 to 4 weeks of age. Heterozygous GJA1M213L/WT mice survived to adulthood with increased ventricular ectopy. Biochemical experiments indicated that cytoplasmic Cx43 had a half-life that was 50% shorter than membrane-associated Cx43. Without GJA1-20k, poorly trafficked Cx43 was degraded. The data support that GJA1-20k, an endogenous entity translated independently of Cx43, is critical for Cx43 gap junction trafficking, maintenance of Cx43 protein, and normal electrical function of the mammalian heart.

Authors

Shaohua Xiao, Daisuke Shimura, Rachel Baum, Diana M. Hernandez, Sosse Agvanian, Yoshiko Nagaoka, Makoto Katsumata, Paul D. Lampe, Andre G. Kleber, TingTing Hong, Robin M. Shaw

×

Figure 4

Localization and expression of full-length Cx43 and Nav1.5 in cardiac ventricles of young (2–3 weeks) M213L mice.

Options: View larger image (or click on image) Download as PowerPoint
Localization and expression of full-length Cx43 and Nav1.5 in cardiac ve...
(A and E) Representative average projected immunofluorescence images of N-cadherin (NCad), full-length (FL) Cx43 (A), and Nav1.5 (E), in cryosections of cardiac ventricles. Cx43 and Nav1.5 are shown in green, and NCad is shown in magenta. Colocalization is shown as white in the merged images. Scale bar: 15 μm. (B and F) Quantification of the immunofluorescence signal of Cx43 (FL) (B) and Nav1.5 (F) at the intercalated discs that are identified with NCad. ****P ≤ 0.0001, Kruskal-Wallis test, followed by Dunn’s multiple-comparisons test, n = 25, 21, and 22 images (B) and n = 34, 29, and 28 images (F) of WT, HT, and HM mice, respectively, with 6 mice in each group. Data represent mean ± SEM. (C and G) Representative Western blots showing the expression of Cx43 (FL) (C) and Nav1.5 (G) protein in the cardiac ventricles of WT, HT, and HM mice. n = 3 experiments. (D and H) Quantification of Cx43(FL) (D) and Nav1.5 (H) protein expression. The values were normalized to GAPDH expression. All graph data represent mean ± SEM. *P ≤ 0.05, Kruskal-Wallis test, followed by Dunn’s multiple-comparisons test, n = 3 mice in each group.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts